CYP3A4 and epilepsy: Thus, the initiation of carbamazepin, a drug known to have a large impact of CYP3A4 and often with a significant clinical impact if combined with other drugs whose metabolism being dependent of this enzyme, [26] was studied in 8 paediatric patients with newly diagnosed epilepsy.